The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable buzz within the industry. A shift away from Schedule I status, often regarded as outdated and hindering https://myeasybookmarks.com/story6341382/marijuana-rescheduling-a-expansion-catalyst